eGFR and coronary artery calcification in chronic kidney disease

Young Youl Hyun1, Hyang Kim1, Kook-Hwan Oh2

  • 1Department of Internal Medicine, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea.

Insights

Lower estimated glomerular filtration rate (eGFR) is linked to coronary artery calcification (CAC) in predialysis chronic kidney disease (CKD) patients. The CKD-EPI creatinine-cystatin equation (eGFRCrCys) better predicts CAC than other formulas.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • The relationship between estimated glomerular filtration rate (eGFR) and coronary artery calcification (CAC) in predialysis chronic kidney disease (CKD) is not fully understood.
  • CKD affects millions globally, increasing cardiovascular risk.

Purpose of the Study:

  • To investigate the association between eGFR, calculated using various equations, and CAC in Korean predialysis CKD patients.
  • To determine which eGFR equation provides the best prediction for CAC in this population.

Main Methods:

  • A cross-sectional study of 1533 predialysis CKD patients from the KNOW-CKD cohort.
  • eGFR was calculated using four equations: MDRD (eGFRMDRD), CKD-EPI creatinine (eGFRCr), CKD-EPI cystatin C (eGFRCys), and CKD-EPI creatinine-cystatin (eGFRCrCys).
  • Coronary artery calcium score (CACS) was measured, with CAC defined as CACS >100.

Main Results:

  • CAC was present in 21.8% of patients and was more common in lower eGFR groups (P < 0.001).
  • Decreasing eGFRCrCys showed a gradual increase in CACS (P for trend = 0.034).
  • Lower eGFRCrCys or eGFRCys levels were associated with increased odds of CAC. The adjusted OR for CAC with eGFR <30 mL/min/1.73 m² vs. eGFR ≥90 mL/min/1.73 m² was 2.64 (95% CI, 1.09-3.60) using eGFRCrCys.
  • Only eGFRCrCys significantly improved CAC prediction models without eGFR (P = 0.046).

Conclusions:

  • A gradual and independent association exists between reduced eGFR and CAC in Korean predialysis CKD patients.
  • The eGFRCrCys equation demonstrated superior predictive performance for CAC compared to other tested equations in this cohort.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
415
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
697
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
613
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
246
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
387